Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AS-2
- Development stage
- Unknown
- Lead developer
- BioQ Pharma
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
AS-2 is an investigational pharmaceutical product being developed by BioQ Pharma for use in anesthesia and sedation. It is part of the company's invenious™ 'connect-and-go' portfolio, which utilizes a proprietary, pre-filled, unit-dose infusion platform. This technology is designed to be deployed quickly at the point of care, aiming to improve clinical efficiency, maintain sterility, and reduce the risk of medication errors associated with traditional drug delivery methods. AS-2 is currently in early-stage development, specifically categorized as being in Phase 1 or preclinical stages within the company's anesthesia and sedation pipeline.
Beyond the preview
Go deeper on AS-2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AS-2.